Healthcare -
Biotechnology - NASDAQ - US
$ 6.57
-16.1 %
$ 37.8 M
Market Cap
-0.26
P/E
Price Target
Average
59.82%
Revenue Forecast
Estimate
132.90%
EBIT
Estimate
57.19%
Net Income
Estimate
45.58%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Atara Biotherapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ATRA of $10.5 , with forecasts ranging from
a
low of
$3 to a high of $18 .
ATRA Lowest Price Target
Wall Street Target
3 USD
-54.34%
ATRA Average Price Target
Wall Street Target
10.5 USD
59.82%
ATRA Highest Price Target
Wall Street Target
18 USD
173.97%
REVENUE FORECAST
Revenue Forecast Chart ATRA
EBIT FORECAST
EBIT Forecast Chart ATRA
NET INCOME FORECAST
Net Income Chart ATRA